High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors

Romain Palich; M. Veyri; A. Vozy; S. Marot; J. Gligorov; M.-A. Benderra; P. Maingon; L. Morand-Joubert; Z. Adjoutah; A.-G. Marcelin; J.-P. Spano; J. Barrière

doi:10.1016/j.annonc.2021.06.018

Journal Articles Annals of Oncology Year : 2021

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors

(1, 2) , (2, 3, 1) , (2, 1, 3) , (2, 1) , (3, 4) , (4, 3) , (2, 3, 1) , (2, 5) , (6) , (2, 1) , (2, 1, 3) ,

1
2
3
4
5
6

Romain Palich

Function : Author
PersonId : 1096380
IdHAL : romain-palich
ORCID : 0000-0003-0047-0101

CHU Pitié-Salpêtrière [AP-HP]

Institut Pierre Louis d'Epidémiologie et de Santé Publique

M. Veyri

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

Institut Universitaire de Cancérologie [Sorbonne Université]

CHU Pitié-Salpêtrière [AP-HP]

A. Vozy

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Pitié-Salpêtrière [AP-HP]

Institut Universitaire de Cancérologie [Sorbonne Université]

S. Marot

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Pitié-Salpêtrière [AP-HP]

J. Gligorov

Function : Author
PersonId : 1172230
IdHAL : joseph-gligorov
ORCID : 0000-0002-9900-6386
IdRef : 093372825

Institut Universitaire de Cancérologie [Sorbonne Université]

CHU Tenon [AP-HP]

M.-A. Benderra

Function : Author

CHU Tenon [AP-HP]

Institut Universitaire de Cancérologie [Sorbonne Université]

P. Maingon

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

Institut Universitaire de Cancérologie [Sorbonne Université]

CHU Pitié-Salpêtrière [AP-HP]

L. Morand-Joubert

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Saint-Antoine [AP-HP]

Z. Adjoutah

Function : Author

Cerballiance

A.-G. Marcelin

Function : Author

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Pitié-Salpêtrière [AP-HP]

J.-P. Spano

Function : Author
PersonId : 1219472
ORCID : 0000-0002-3921-2479
IdRef : 050773631

Institut Pierre Louis d'Epidémiologie et de Santé Publique

CHU Pitié-Salpêtrière [AP-HP]

Institut Universitaire de Cancérologie [Sorbonne Université]

J. Barrière

Function : Author

Keywords

Cancer SARS-CoV-2 COVID-19 mRNA vaccine Vaccination Serology

Domains

Vaccinology Infectious diseases Emerging diseases Cancer

Fichier principal

Palich et al. - 2021 - High seroconversion rate but low antibody titers a.pdf (280.43 Ko)

Origin	Files produced by the author(s)

Gestionnaire HAL 3 Sorbonne Université : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03273233

Submitted on : Tuesday, June 29, 2021-9:32:22 AM

Last modification on : Friday, December 22, 2023-10:24:36 AM

Long-term archiving on : Thursday, September 30, 2021-6:13:11 PM

Dates and versions

hal-03273233 , version 1 (29-06-2021)

Identifiers

HAL Id : hal-03273233 , version 1
DOI : 10.1016/j.annonc.2021.06.018

Cite

Romain Palich, M. Veyri, A. Vozy, S. Marot, J. Gligorov, et al.. High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors. Annals of Oncology, In press, ⟨10.1016/j.annonc.2021.06.018⟩. ⟨hal-03273233⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CNRS IPLESP SORBONNE-UNIVERSITE SU-MEDECINE

47 View

41 Download

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated by chemotherapy for solid cancers Authors

Keywords

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share